Combating the Eosinophil with Anti–Interleukin-5 Therapy  

Oleh:

Wechsler, Michael E.

Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: The New England Journal of Medicine (keterangan: ada di Proquest) vol. 358 no. 12 (Mar. 2008), page 1293.

Ketersediaan

Perpustakaan FK Nomor Panggil: N08.K.2008.02 Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada

Lihat Detail Induk

Isi artikel

The role of eosinophils in common diseases — such as asthma, parasitic disease, or allergic reactions — remains speculative. Even more puzzling is the eclectic group of rare disorders that constitute the hypereosinophilic syndromes. These syndromes are characterized by persistently high levels of blood eosinophils and their toxic mediators (e.g., eosinophilic cationic protein and eosinophil-derived neurotoxin), accompanied by severe multiorgan damage.1 The hypereosinophilic syndromes exclude secondary causes of eosinophilia such as infection while including myeloproliferative and lymphoproliferative variants, associated eosinophilic conditions that fulfill specific diagnostic criteria (e.g., the Churg–Strauss syndrome and mastocytosis), and the complex, undefined conditions affecting a large . . .

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali